Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jun Yu
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0000-0003-3435-6550
Observed ORCID:
0000-0003-3435-6550
OpenAlex ID:
A5123452065
Pathomics Signature for Prognosis and CA19‐9 Interception in Pancreatic Ductal Adenocarcinoma: A Real‐Life, Multi‐Center Study
2026
·
Qiangda Chen
, Zhihang Xu
, et al.
·
Advanced Science
·
6
Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
2026
·
Xiaofan Guo
, Yuxiao Liu
, et al.
·
Signal Transduction and Targeted Therapy
·
2
PDF
Abstract 240: Allele-specific sensitization of pancreatic ductal adenocarcinoma to PARP inhibition via adenine base editing.
2026
·
Jin Zhang
, Jingrui Yan
, et al.
·
Cancer Research
Abstract 7010: Trogocytosis-orchestrated CLDN18.2-dressed CD8+ T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence-cascade
2026
·
Jingrui Yan
, Tianxing Zhou
, et al.
·
Cancer Research
Show more works
View as search
Works count:
4
Citation count:
8
H-index:
2
I10-index:
Year
Topic
Type